Tag: https://www.bio.org/events/bio-international-convention

Apr 22

Phyllis Arthur – POLITICO's Inaugural Health Care Summit – The Many Legacies of Covid

Phyllis Arthur, Vice President, Infectious Diseases and Diagnostics Policy, BIO, participated on a panel discussion, “The Many … source

Apr 21

Scott DeWire, Head of Business Development & Licensing USA, Boehringer-Ingelheim – BIO2022

2022 BIO International Convention is Back in Person! For the first time in two years, the BIO International Convention will be back … source

Apr 20

Dr. Cartier Esham's Testimony at the Senate Committee on Health, Education, Labor & Pensions Hearing

Highlights of BIO’s Chief Scientific Officer, Dr. Cartier Esham’s testimony at the U.S. Senate Committee on Health, Education, Labor and Pensions Hearing, “FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients,” on April 5, 2022. source

Apr 19

Dr. Michelle McMurry-Heath, Endpoints: Making Innovation Matter by Ensuring Access to Cancer Care

BIO CEO Dr. Michelle McMurry-Heath joined an Endpoints webinar sponsored by Takeda entitled ‘Making innovation matter by ensuring access to cancer care.’ Moderated by BIO Executive Committee Member Liz Lewis, Dr. McMurry-Heath’s panel included representatives from LUNGevity and Humana, with the four covering topics such as innovating and improving efficiencies in the benefit and payer […]

Apr 18

BIO 2022 Overview and Partnering Basics Webinar

BIO is committed to unlocking possibilities for our members and attendees while paving the path to the future of our industry. source